ArticleInternational braz j urol : official journal of the Brazilian Society of Urology
Suture versus Sutureless Retroperitoneal Robot-assisted Partial Nephrectomy using Veriset™ Hemostatic Patch: A Propensity Score Matched Comparative Analysis from a Single Centre.
Article in International braz j urol : official journal of the Brazilian Society of Urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the efficacy of Veriset™ hemostatic patch as a substitute for conventional renorrhaphy in retroperitoneal robot-assisted partial nephrectomy (RAPN). MATERIALS AND
methodsA total of 113 patients underwent retroperitoneal RAPN between January 2024 and January 2025. After propensity score matching on age, BMI, and R.E.N.A.L nephrometry score, 32 and 40 patients underwent Veriset™ placement and renorrhaphy, respectively, were included for final analysis. The clinico-demographic data, R.E.N.A.L. nephrometry score, blood loss, hemoglobin-drop, hospital stay, complications, and renal function on follow-up were prospectively recorded.
resultsThe mean age, body-mass-index, and R.E.N.A.L. score were 52.6 ± 9.86 years, 27.41 ± 4.06 kg/m2, and 5.24 ± 1.17, respectively. As per the low, intermediate, and high-risk categories of nephrometry, the patients were evenly distributed. The console time and warm ischemia time (WIT) were significantly less in the Veriset group (47.26 ± 17.51 vs. 71.67 ± 22.6 minutes, and 12.86 ± 6.14 vs 17.48 ± 5.40 minutes, respectively, p<0.001). Blood loss was significantly higher in the renorrhaphy group (57.74 ± 22.83 vs. 87.34 ± 33.81 mL, p=0.008). The change in GFR was significantly less in the Veriset group on postoperative day-1 (p=0.008), but became comparable after six months. The postoperative pain score at 6, 12, and 24 hours, blood transfusion, hospital stay, and readmission rates were similar in both groups.
conclusionAs compared to the renorrhaphy group, Veriset group patients had less console time, WIT, blood loss and immediate reduction of GFR. Sutureless retroperitoneal RAPN can produce good perioperative results without increasing complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.